MoonLake Immunotherapeutics (MLTX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$227.32M | -91.1% |
| 2024 | -$118.94M | -230.3% |
| 2023 | -$36.01M | +27.9% |
| 2022 | -$49.97M | -1000.1% |
| 2021 | -$4.54M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$227.32M | -91.1% |
| 2024 | -$118.94M | -230.3% |
| 2023 | -$36.01M | +27.9% |
| 2022 | -$49.97M | -1000.1% |
| 2021 | -$4.54M | — |